Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$490M |
| 2 |
Duke Energy
DUK
|
+$303M |
| 3 |
Gilead Sciences
GILD
|
+$164M |
| 4 |
LNKD
LinkedIn Corporation
LNKD
|
+$159M |
| 5 |
Cisco
CSCO
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
KLA
KLAC
|
+$274M |
| 3 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$235M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$225M |
| 5 |
Microsoft
MSFT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.55% |
| 2 | Healthcare | 3.86% |
| 3 | Financials | 3.37% |
| 4 | Consumer Discretionary | 2.98% |
| 5 | Communication Services | 2.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXA
5276
DELISTED
EXA Corporation
EXA
| $24K | ﹤0.01% |
+1,530
| New | +$23K |
|
|
MHGC
5277
DELISTED
Morgans Hotel Group Co.
MHGC
| $24K | ﹤0.01% |
11,776
+1,963
| +20% | +$4.37K |
|
|
FMSA
5278
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $24K | ﹤0.01% |
2,787
-2,715
| -49% | -$20.2K |
|
5279
Aegon
AEG
$14B
| $23K | ﹤0.01% |
7,731
+7,004
| +963% | +$20.9K |
|
5280
Braskem
BAK
$928M
| $23K | ﹤0.01% |
1,496
+1,369
| +1,078% | +$17.9K |
|
5281
Comtech Telecommunications
CMTL
$50.3M
| $23K | ﹤0.01% |
1,752
-2,566
| -59% | -$33.7K |
|
5282
CONMED
CNMD
$1.39B
| $23K | ﹤0.01% |
564
-9,317
| -94% | -$396K |
|
5283
CareTrust REIT
CTRE
$9.91B
| $23K | ﹤0.01% |
1,501
+1,194
| +389% | +$17.5K |
|
5284
First Merchants
FRME
$2.68B
| $23K | ﹤0.01% |
+871
| New | +$23K |
|
5285
iShares Russell Mid-Cap ETF
IWR
$56B
| $23K | ﹤0.01% |
528
| – | – |
|
5286
Lakeland Financial Corp
LKFN
$1.56B
| $23K | ﹤0.01% |
640
+572
| +841% | +$19.8K |
|
5287
Merit Medical Systems
MMSI
$5.08B
| $23K | ﹤0.01% |
938
+809
| +627% | +$18.7K |
|
5288
PUT
Pilgrim's Pride
PPC
$6.51B
| $23K | ﹤0.01% |
1,100
-99,600
| -99% | -$2.31M |
|
5289
RadNet
RDNT
$5.02B
| $23K | ﹤0.01% |
3,015
+2,794
| +1,264% | +$17.8K |
|
|
RGLS
5290
DELISTED
Regulus Therapeutics
RGLS
| $23K | ﹤0.01% |
59
-3
| -5% | -$1.23K |
|
5291
RE/MAX Holdings
RMAX
$193M
| $23K | ﹤0.01% |
497
+462
| +1,320% | +$19.5K |
|
5292
Sprott Junior Gold Miners ETF
SGDJ
$267M
| $23K | ﹤0.01% |
560
| – | – |
|
5293
S&T Bancorp
STBA
$1.84B
| $23K | ﹤0.01% |
799
+746
| +1,408% | +$20.1K |
|
5294
Titan Machinery
TITN
$396M
| $23K | ﹤0.01% |
2,228
-11,362
| -84% | -$126K |
|
5295
CALL
Trimble
TRMB
$13.2B
| $23K | ﹤0.01% |
800
-3,000
| -79% | -$80.2K |
|
5296
United Fire Group
UFCS
$1.32B
| $23K | ﹤0.01% |
561
+522
| +1,338% | +$22.2K |
|
5297
Xencor
XNCR
$1.5B
| $23K | ﹤0.01% |
923
+846
| +1,099% | +$17.9K |
|
|
TEN
5298
PUT
Tsakos Energy Navigation Ltd
TEN
$1.21B
| $23K | ﹤0.01% |
960
+380
| +66% | +$9.51K |
|
|
DBGR
5299
DELISTED
Xtrackers MSCI Germany Hedged Equity ETF
DBGR
| $23K | ﹤0.01% |
1,000
| – | – |
|
|
BPFH
5300
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $23K | ﹤0.01% |
1,801
-12,350
| -87% | -$153K |
|
Similar funds
Barclays's Q3 2016 Portfolio in Review
As of Q3 2016, Barclays held 7,163 positions worth $90.1B, up 17% from $76.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $9.06B of net new capital in Q3 2016, opening 665 new positions and adding to 2,829 existing holdings. Its largest new stake was Dell: 9,434,097 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 4.5% of assets, down from 5.6% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $593M trimmed.
- Barclays's largest Q3 2016 buy was Dell: 9,434,097 shares worth $127M.
- Barclays added most to Procter & Gamble in Q3 2016, an estimated $490M increase.
- Barclays's biggest Q3 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $593M.
- Barclays fully exited EMC CORPORATION in Q3 2016, selling an estimated $225M.
- Barclays's ten largest holdings make up 36% of its $90.1B portfolio in Q3 2016.
- Barclays opened 665 new positions and closed 446 in Q3 2016.
- Barclays's portfolio value rose 17% quarter-over-quarter to $90.1B.
Based on Barclays's 13F filing for Q3 2016, filed 14 Nov 2016.